癌症中的表观基因组编辑:潜在治疗选择的进展和挑战
Seung-Won Lee1, Connor Mitchell Frankston2, Jungsun Kim3
1Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States; Department of Molecular and Medical Genetics, School of Medicine, Oregon Health & Science University, Portland, OR, United States.
International review of cell and molecular biology
|February 15, 2024
概括
受环境因素影响的表观遗传变化有助于癌症的发展. 新兴的表观遗传编辑技术为癌症治疗和治疗策略提供了有前途的新途径.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 癌症由遗传和非遗传因素引起,表观遗传变化起着关键作用.
- 表观遗传变化可以影响瘤抑制基因和瘤基因,导致细胞异常状态.
- 越来越多的环境影响被认为是导致癌症表观遗传修饰的因素.
研究的目的:
- 审查当前对癌症表观遗传变化的理解.
- 探索表观遗传编辑技术在癌症治疗中的潜力.
- 弥合表观遗传学研究和治疗应用之间的差距.
主要方法:
- 对各种癌症表观遗传变化的文献综述.
- 对当前适用于表观遗传学的基因编辑技术的分析.
- 在表观遗传疗法中讨论临床前和临床研究.
主要成果:
- 表观遗传修饰是癌症的标志,影响基因表达和细胞功能.
- 基因编辑工具,如基于CRISPR的表观遗传编辑器,正在迅速发展.
- 这些技术显示了针对癌症相关表观遗传变化的有针对性的逆转的潜力.
结论:
- 表观遗传改变是癌症发展和进展的关键驱动因素.
- 表观遗传编辑为精确瘤学提供了一个新的治疗前沿.
- 需要进一步的研究才能将这些技术转化为有效的癌症治疗方法.
更多相关视频
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
CRISPR
51.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.0K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
What is Genetic Engineering?
74.1K
Overview
74.1K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


